Huang, J. ; Huth, C. ; Covic, M. ; Troll, M. ; Adam, J. ; Zukunft, S. ; Prehn, C. ; Wang, L. ; Nano, J. ; Scheerer, M.F. ; Neschen, S. ; Kastenmüller, G. ; Suhre, K.* ; Laxy, M. ; Schliess, F.* ; Gieger, C. ; Adamski, J. ; Hrabě de Angelis, M. ; Peters, A. ; Wang-Sattler, R.
     
    
        
Machine learning approaches reveal metabolic signatures of incident chronic kidney disease in individuals with prediabetes and type 2 diabetes.
    
    
        
    
    
        
        Diabetes 69, 2756-2765 (2020)
    
    
    
      
      
	
	    Early and precise identification of individuals with pre-diabetes and type 2 diabetes (T2D) at risk for progressing to chronic kidney disease (CKD) is essential to prevent complications of diabetes. Here, we identify and evaluate prospective metabolite biomarkers and the best set of predictors of CKD in the longitudinal, population-based Cooperative Health Research in the Region of Augsburg (KORA) cohort by targeted metabolomics and machine learning approaches. Out of 125 targeted metabolites, sphingomyelin C18:1 and phosphatidylcholine diacyl C38:0 were identified as candidate metabolite biomarkers of incident CKD specifically in hyperglycemic individuals followed during 6.5 years. Sets of predictors for incident CKD developed from 125 metabolites and 14 clinical variables showed highly stable performances in all three machine learning approaches and outperformed the currently established clinical algorithm for CKD. The two metabolites in combination with five clinical variables were identified as the best set of predictors, and their predictive performance yielded a mean area value under the receiver operating characteristic curve of 0.857. The inclusion of metabolite variables in the clinical prediction of future CKD may thus improve the risk prediction in people with prediabetes and T2D. The metabolite link with hyperglycemia-related early kidney dysfunction warrants further investigation.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Risk; Sphingomyelin; Prediction; Albuminuria; Progression; Population; Children
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2020
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2020
    
 
    
    
        ISSN (print) / ISBN
        0012-1797
    
 
    
        e-ISSN
        1939-327X
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 69,  
	    Issue: 12,  
	    Pages: 2756-2765 
	    Article Number: ,  
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            American Diabetes Association
        
 
        
            Publishing Place
            Alexandria, VA.
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30202 - Environmental Health
90000 - German Center for Diabetes Research
30201 - Metabolic Health
30505 - New Technologies for Biomedical Discoveries
    
 
    
        Research field(s)
        Genetics and Epidemiology
Enabling and Novel Technologies
    
 
    
        PSP Element(s)
        G-504091-003
G-504090-001
G-504000-006
G-504091-002
G-504091-004
G-501900-061
G-505600-003
G-504000-002
G-501900-062
G-503700-001
G-505300-002
G-500600-001
G-504000-010
G-501900-401
    
 
    
        Grants
        Biomedical Research Program funds at Weill Cornell Medicine -Qatar, a program - Qatar Foundation
EIT, a body of the European Union
European Institute of Innovation and Technology (EIT) Health
European Union Seventh Framework Programme (EU FP7)
Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ
State of Bavaria
Helmholtz Zentrum Munchen -German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2020-10-15